標(biāo)題: Titlebook: Biomedical Product Development: Bench to Bedside; Babak Arjmand,Moloud Payab,Parisa Goodarzi Textbook 2020 Springer Nature Switzerland AG [打印本頁(yè)] 作者: miserly 時(shí)間: 2025-3-21 19:02
書目名稱Biomedical Product Development: Bench to Bedside影響因子(影響力)
書目名稱Biomedical Product Development: Bench to Bedside影響因子(影響力)學(xué)科排名
書目名稱Biomedical Product Development: Bench to Bedside網(wǎng)絡(luò)公開度
書目名稱Biomedical Product Development: Bench to Bedside網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Biomedical Product Development: Bench to Bedside被引頻次
書目名稱Biomedical Product Development: Bench to Bedside被引頻次學(xué)科排名
書目名稱Biomedical Product Development: Bench to Bedside年度引用
書目名稱Biomedical Product Development: Bench to Bedside年度引用學(xué)科排名
書目名稱Biomedical Product Development: Bench to Bedside讀者反饋
書目名稱Biomedical Product Development: Bench to Bedside讀者反饋學(xué)科排名
作者: progestogen 時(shí)間: 2025-3-21 23:28 作者: Stricture 時(shí)間: 2025-3-22 03:08 作者: arthroscopy 時(shí)間: 2025-3-22 05:54 作者: ENDOW 時(shí)間: 2025-3-22 08:52 作者: Orgasm 時(shí)間: 2025-3-22 15:45
2509-6125 Ph.D. students) in the field of molecular medicine, medical biotechnology, stem cell research and related areas, as well as for professionals such as quality control staff, tissue bankers, policy-makers and he978-3-030-35625-5978-3-030-35626-2Series ISSN 2509-6125 Series E-ISSN 2509-6133 作者: 業(yè)余愛好者 時(shí)間: 2025-3-22 20:56
Preclinical Studies for Development of Biomedical Products,eatments. Accordingly, this chapter has a special focus on preclinical study principles, essentials, and its translational importance in bioscience. At the beginning of this chapter, the general definition of preclinical studies and its rationale and importance will be discussed. Then, some of the e作者: Morose 時(shí)間: 2025-3-23 01:05 作者: DEI 時(shí)間: 2025-3-23 01:44 作者: IRATE 時(shí)間: 2025-3-23 06:42 作者: Infinitesimal 時(shí)間: 2025-3-23 12:30 作者: gangrene 時(shí)間: 2025-3-23 13:58
Safety Concerns and Requirement of Cell-Based Products for Clinical Application,d is safety. Challenges of safety consideration and efficacy of human cell-based products need to be further addressed. Safety concerns depend on many risk factors including intrinsic, extrinsic, and associated with clinical characteristics. This chapter explains importance of safety. Thereafter, several risk factors will be described.作者: GLIB 時(shí)間: 2025-3-23 21:18
Standards and Regulatory Frameworks (for Cell- and Tissue-Based Products),ducts (HCTPs) in their structure, content, mode of action, and delivery confronts health relevant professionals, regulatory authorities, and manufacturers with some challenges from product design to delivery [1].作者: LASH 時(shí)間: 2025-3-24 00:46
https://doi.org/10.1007/978-0-387-78864-7940s. Quality in the laboratory means to have a traceable and accurate test results. Accordingly, any level of inaccuracy should be avoided. On the other hand, in the field of biomedical product manufacturing, achieving a safe and efficient product needs implementing all of the aspects of the qualit作者: 水土 時(shí)間: 2025-3-24 03:34
https://doi.org/10.1007/978-0-387-78864-7ology laboratories and increase the number of laws for chemical and pharmaceutical products [1]. They discovered a lot of fraudulent activities and poor laboratory practices such as uncalibrated equipment, wrong measurements, inaccurate data, and inadequate test systems. Accordingly, by setting GLP 作者: 百科全書 時(shí)間: 2025-3-24 09:10 作者: spondylosis 時(shí)間: 2025-3-24 12:45
https://doi.org/10.1007/978-0-387-78864-7 hormones affect the human body? Unfortunately, it is not usually possible to address these questions through performing relevant tests on human population. Hence, developing animal models which properly mimic the human pathophysiology to generate different human disease situations is a suitable alt作者: Parameter 時(shí)間: 2025-3-24 16:24
https://doi.org/10.1007/978-0-387-78864-7ustrial revolution altered the concept of quality drastically. Rise of inspections and separation of quality departments were the main outcomes of this alteration. On the other hand, statistical methods were the unprecedented approach to control the products variabilities and quality. In addition to作者: NOCT 時(shí)間: 2025-3-24 21:58 作者: 雪白 時(shí)間: 2025-3-25 02:02
https://doi.org/10.1007/978-0-387-78864-7ducts (HCTPs) in their structure, content, mode of action, and delivery confronts health relevant professionals, regulatory authorities, and manufacturers with some challenges from product design to delivery [1].作者: 發(fā)微光 時(shí)間: 2025-3-25 05:18
https://doi.org/10.1007/978-0-387-78864-7rdingly, good clinical practice (GCP) is an international ethical and scientific quality standard for conducting the trials involving human subjects. In this chapter, a brief history of GCP, leading to its importance and functions, will be discussed. Then, we will go through some details about its p作者: 說明 時(shí)間: 2025-3-25 08:10 作者: landmark 時(shí)間: 2025-3-25 12:07
https://doi.org/10.1007/978-0-387-78864-7ities. Accordingly, in this chapter, all aspects of GCP will be discussed in detail. Before conducting the trial, there are some requirements such as justification of the research?– especially ethical wise?– and establishment of procedures for documentation. Further, the risk management processes an作者: tooth-decay 時(shí)間: 2025-3-25 17:15
https://doi.org/10.1007/978-0-387-78864-7, Tuskegee, Willowbrook, Milgram, Stanford Prison, etc.). Tuskegee Syphilis Study, for instance, is conducted by the U.S. Public Health Service (1932–1972). In this study, 400 subjects out of 600 African-American males from a low social economic population were infected with syphilis and observed fo作者: 沙草紙 時(shí)間: 2025-3-25 20:52 作者: Afflict 時(shí)間: 2025-3-26 02:15 作者: prick-test 時(shí)間: 2025-3-26 06:54
https://doi.org/10.1007/978-0-387-78864-7d is safety. Challenges of safety consideration and efficacy of human cell-based products need to be further addressed. Safety concerns depend on many risk factors including intrinsic, extrinsic, and associated with clinical characteristics. This chapter explains importance of safety. Thereafter, several risk factors will be described.作者: 迅速成長(zhǎng) 時(shí)間: 2025-3-26 10:19
https://doi.org/10.1007/978-0-387-78864-7ducts (HCTPs) in their structure, content, mode of action, and delivery confronts health relevant professionals, regulatory authorities, and manufacturers with some challenges from product design to delivery [1].作者: 催眠藥 時(shí)間: 2025-3-26 15:04
https://doi.org/10.1007/978-0-387-78864-7This chapter is trying to learn:作者: 欺騙世家 時(shí)間: 2025-3-26 20:37 作者: 邊緣帶來墨水 時(shí)間: 2025-3-26 21:21 作者: ICLE 時(shí)間: 2025-3-27 03:07 作者: MILL 時(shí)間: 2025-3-27 06:26 作者: DAUNT 時(shí)間: 2025-3-27 12:56 作者: 偶然 時(shí)間: 2025-3-27 15:13 作者: 功多汁水 時(shí)間: 2025-3-27 20:27
https://doi.org/10.1007/978-0-387-78864-7justification of the research?– especially ethical wise?– and establishment of procedures for documentation. Further, the risk management processes and principles are other essential parts of GCP which will be addressed. Finally, the most important challenges and different ways to overcome them will be introduced.作者: scotoma 時(shí)間: 2025-3-27 22:42
Good Clinical Practice: Guidelines and Requirements,justification of the research?– especially ethical wise?– and establishment of procedures for documentation. Further, the risk management processes and principles are other essential parts of GCP which will be addressed. Finally, the most important challenges and different ways to overcome them will be introduced.作者: 棲息地 時(shí)間: 2025-3-28 02:48 作者: exigent 時(shí)間: 2025-3-28 07:41
https://doi.org/10.1007/978-0-387-78864-7e participants will be demonstrated, and intervention includes concepts like diagnostic intervention. Furthermore, a snapshot of clinical trial monitoring, risk assessment, and its various types will be exhibited with a brief focus on registration and obstacles.作者: 戰(zhàn)勝 時(shí)間: 2025-3-28 12:15
Principles of Good Clinical Practice,hich you will be faced with using the guidelines, there are some examples about different kinds of GCP guidelines around the world to show how it is implemented and influences the performance and management of clinical trials.作者: 憂傷 時(shí)間: 2025-3-28 16:04 作者: 飾帶 時(shí)間: 2025-3-28 20:36 作者: 教義 時(shí)間: 2025-3-29 00:59 作者: 攝取 時(shí)間: 2025-3-29 05:54 作者: WATER 時(shí)間: 2025-3-29 07:32
Principles of Good Laboratory Practice (GLP),l risk management. Moreover, it is important to know how scientists use quality setting to improve biological products and data. Finally, research authorities should prove that there are no changes in the quality of data [1, 3].作者: 舉止粗野的人 時(shí)間: 2025-3-29 11:54 作者: 吸氣 時(shí)間: 2025-3-29 19:05 作者: 食道 時(shí)間: 2025-3-29 22:39
Principles of Good Laboratory Practice (GLP),ology laboratories and increase the number of laws for chemical and pharmaceutical products [1]. They discovered a lot of fraudulent activities and poor laboratory practices such as uncalibrated equipment, wrong measurements, inaccurate data, and inadequate test systems. Accordingly, by setting GLP 作者: ACME 時(shí)間: 2025-3-30 00:40
Design of Experimental Studies in Biomedical Sciences,fundamental importance. Well-designed experimental studies with considering key points which are appropriately analyzed and reported could maximize scientific gains. However, there are still some problems in this process that should be addressed. Accordingly, using adequate methods based on the aim 作者: Left-Atrium 時(shí)間: 2025-3-30 05:46 作者: 反對(duì) 時(shí)間: 2025-3-30 11:12
